🔬 Focusing on delivering the world's latest scientific research, authoritative clinical trial results and industry policy interpretation, covering neural stem cell transplantation, mesenchymal stem cells, immune cell therapy (e.g. CAR-T) and other cutting-edge technologies.

Hangi Stem Cell Life Sciences

间充质干细胞 - 杭吉干细胞生命科技

156例患者研究证实:间充质干细胞联合神经干细胞治疗脑梗死可双重改善神经功能与脑灌注
mesenchymal stem cell MSC (in cell biology)

156例患者研究证实:间充质干细胞联合神经干细胞治疗脑梗死可双重改善神经功能与脑灌注

阅读(558) Author (admin)

急性脑梗死(ACI)是导致全球范围内高死亡率与致残率的主要脑血管疾病,其病理基础是血管阻塞导致的脑组织缺血坏死。尽管现有血管再通治疗(如溶栓、取栓)能有效实现血运重建,但对于神经功能的长期恢复往往效果……

干细胞治疗帕金森病取得新进展!II期临床证实:3次输注,安全且运动功能得到改善
stem cell therapy

Stem Cell Therapy for Parkinson's Disease Advances: 3 Infusions Safe and Improved Motor Function Confirmed in Phase II Clinic

阅读(1,023) Author (admin)

Since the 1960s, when Carlsson, Hornykiewicz, Cotzias, and Yahr discovered nigrostriatal dopamine deficiency in patients with Parkinson's disease (PD) and introduced dopamine replacement therapy, a plethora of pharmacologic and neuromodulatory treatments have been effective in alleviating motor symptoms. In the field of regenerative medicine, PD has been a cell therapy ......